[Federal Register Volume 61, Number 114 (Wednesday, June 12, 1996)] [Notices] [Page 29769] From the Federal Register Online via the Government Publishing Office [www.gpo.gov] [FR Doc No: 96-14795] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Notice Pursuant to the National Cooperative Research and Production Act of 1993--Inter Company Collaboration for Aids Drug Development Notice is hereby given that, on May 24, 1996, pursuant to Section 6(a) of the National Cooperative Research and Production Act of 1993, 15 U.S.C. Sec. 4301 et seq. (``the Act''), Inter Company Collaboration for Aids Drug Development (The Collaboration) filed written notifications simultaneously with the Attorney General and the Federal Trade Commission reflecting changes in membership. The notifications were filed for the purpose of extending the Act's provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances. The changes are that Triangle Pharmaceuticals, Inc., of Durham, North Carolina and Agouron Pharmaceuticals, Inc., of La Jolla, California, have become members of the Collaboration. No other changes have been made in either the membership or planned activities of the Collaboration. Membership in the Collaboration remains open, and the Collaboration intends to file additional written notifications disclosing all changes in membership. On My 27, 1993, the Collaboration filed its original notification pursuant to Section 6(a) of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6(b) of the Act on July 6, 1993 (58 FR 36223). The last notification was filed with the Department on May 18, 1995. A notice was published in the Federal Register on February 23, 1996 (61 FR 7019). Constance K. Robinson, Director of Operations Antitrust Division. [FR Doc. 96-14795 Filed 6-11-96; 8:45 am] BILLING CODE 4410-01-M